Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 76   

Articles published

CBST 62.62 -3.08 (-4.69%)
price chart
Cubist Pharma To Present At JMP Securities Conference; Webcast At 1:30 PM ET
( - Cubist Pharmaceuticals Inc ( CBST ) will present at the JMP Securities Healthcare Conference in Westin New York Grand Central,� New York City.
Top Decliners in Focus: Unisys Corporation (UIS), CONMED Corporation ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) fell more than 5 percent in the current trading session after JMP Securities lowered its ratings for the biopharmaceutical company from �Outperform� to �Market Perform� in a research report released on 23rd of July.
Hottest Healthcare Stocks Now - PBYI INO ISRG BIIB
Healthcare stocks advanced broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 0.6%. More broadly, the Dow Jones Industrial Average remained flat, the Nasdaq increased 0.3% and the S&P 500 was unchanged.
Related articles »  
First Week of CBST September 20th Options Trading
Investors in Cubist Pharmaceuticals Inc. (Symbol: CBST) saw new options begin trading this week, for the September 20th expiration.
Morning Market Losers
Cubist Pharmaceuticals (NASDAQ: CBST) fell 8.34% to $60.22 after the company reported Q2 earnings of $0.23 per share on revenue of $294.40 million.
Related articles »  
Analysts' Actions: McDonald's, Xilinx, Microsoft, DuPont, More
$45 12-month price target. Cubist Pharmaceuticals (CBST) was downgraded at JMP Securities to market perform from outperform.
Omnicare's (OCR) CEO Nitin Sahney on Q2 2014 Results - Earnings Call ...
You are also cautioned that any forward-looking statements reflect management's current views only and that the Company undertakes no obligation to revise or update such statements in the future. For simplicity sake and to focus on what we believe are ...
Related articles »  
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22 ...
LEXINGTON, Mass., Jul 15, 2014 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) will issue its second quarter 2014 financial results at 4:00 p.m.
Related articles »  
Cubist holds first ever volunteer day at charities around Boston
In a brief interview this morning, Bonney said that while the company has long focused on STEM education and matching gifts program, its recent growth has spurred a desire to do more.
Healthcare Gainers: Halozyme Therapeutics, (NASDAQ:HALO), Catalyst ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) moved a step closer towards achieving its objective of having four antibiotics in the market by 2015 when the FDA approved Sivextro (200 mg: once daily for six days).
Related articles »